Oslo, August 13, 2024 - Observe Medical ASA (the "Company" or "Observe Medical")
announces the appointment of Jørgen Mann as its permanent Chief Executive
Officer ("CEO").

Having served as interim CEO since February 2024, Mr. Mann has proven his
leadership capabilities and deep insight into the Company's strategic
operations. The board is fully confident in his ability to steer Observe Medical
into its next phase, focusing on commercial milestones, growth, and innovation.
His leadership is expected to be crucial as the Company moves forward with its
ambitious goals in the healthcare sector.

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Terje Bakken, Chairman Observe Medical
Mobile: +47 934 33 321
E-mail: tb@reitenco.no

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.